HERCEPTIN Pages on BioPortfolio:

Biotechnology News HERCEPTIN Search
27 Oct 2009 ... More women on 12 month Herceptin course - Nearly 200 New Zealand .... The drug - trastuzumab (herceptin) - inhibits cancer cell survival. ...
http://www.bioportfolio.co.uk/HERCEPTIN-news.htm...

BioPortfolio - Herceptin
Herceptin - BioPortfolio - Indepth. ... Companies working in the area of Herceptin from Bioportfolio's Biocorporate database : BioPortfolio Logo ...
http://www.bioportfolio.com/indepth/Herceptin.html...

Biotechnology News heart mcdonald. herceptin. canadian ...
(Ivanhoe Newswire) -- Canadian cardiologists have taken a step toward clearing the drug trastuzumab (herceptin) for use in the fight against breast cancer, ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

BioPortfolio - Halozyme Therapeutics - Profile
Halozyme, Roche Initiate Phase 3 Trial For Herceptin ... Halozyme Announces Roche Doses First Patient in Phase 3 Clinical Trial with Subcutaneous Herceptin
...
http://www.bioportfolio.com/biocorporate/23804-Halozyme%2525...

BioPortfolio - Monogram Biosciences, Inc. - Monogram Announces ...
2 Jun 2008 ... "Current testing methods for determination of the likelihood of benefit from Herceptin are not adequate," said ...
http://www.bioportfolio.com/news/Monogram_Announces_Presenta...

BioPortfolio Biotechnology BioNews : live article
"Building upon the foundation laid by Rituxan, Herceptin, Avastin and Tarceva, we hope that these new investigational molecules may one day become part of ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...

BioPortfolio Limited Global Biotech Market Analysis and Forecasts ...
4.10.2 Development of Herceptin 4.11 Epogen Sales Outlook from 2008 Onwards .... Figure 4.11 World Revenues ($m) for Herceptin 2008-2013, 2018 & 2023 ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_602.html...

BioPortfolio.com - BioWeb OMNITROPE SOMATROPIN RECOMBINANT isrupt ...
Home Contact Us Site Index Search [ Products -- Nutropin ] Products Home ONCOLOGY Avastin Herceptin Rituxan Tarceva IMMUNOLOGY Raptiva Xolair VASCULAR
...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?DB=se...

Antibody Therapeutics - Product Development, Market Trends, and ...
The worldwide half yearly sales of Herceptin(R) during the first half of 2006 ... Further growth in the Herceptin(R) market is predicted and the annual peak
...
http://www.bioportfolio.com/cgi-bin/acatalog/Antibody_Therap...

Results from other life science and pharmaceutical sites:

Trastuzumab - Wikipedia, the free encyclopedia
Trastuzumab (Herceptin) is a monoclonal antibody that interferes with the ..... Her-2: the making of Herceptin, a revolutionary treatment for breast cancer. ...
http://en.wikipedia.org/wiki/Trastuzumab...

Genentech: Medicines: Herceptin
Herceptin is the approved antibody for the treatment of metastatic breast cancer for patients whose tumors overexpress the HER2 protein and who have not ...
http://www.gene.com/gene/products/information/oncology/herce...

Roche - Herceptin provides impressive survival benefit for ...
24 Sep 2009 ... Overall survival for patients with high levels of HER2 receiving Herceptin was 16 months on average versus 11.8 months for patients ...
http://www.roche.com/media/media_releases/med-cor-2009-09-24...

Herceptin (R) Combined With Chemotherapy Improves Disease-Free ...
25 Apr 2005 ... Herceptin® Combined With Chemotherapy Improves Disease–Free Survival for Patients With Early–Stage Breast Cancer ...
http://www.nih.gov/news/pr/apr2005/nci-25.htm...

Genentech: Investors: Herceptin - Historical Sales
Skip to Content for Herceptin - Historical Sales Menu for Herceptin - Historical Sales About Us Menu Research Menu Development Menu Medicines Menu Investors ...
http://www.gene.com/gene/ir/financials/historical/herceptin....

Roche - Herceptin landmark study (ToGA) reveals unprecedented ...
31 May 2009 ... The international phase III study also showed that Herceptin reduces the risk of death in patients with HER2-positive advanced and ...
http://www.roche.com/media/media_releases/med-cor-2009-05-31...

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not ...
Herceptin safely and effectively. See full prescribing information for ..... Adverse reactions requiring interruption or discontinuation of Herceptin ...
http://www.gene.com/gene/products/information/pdf/herceptin-...

Herceptin-induced inhibition of phosphatidylinositol-3 kinase and ...
Herceptin-induced inhibition of phosphatidylinositol-3 kinase and Akt Is required for antibody-mediated effects on p27, cyclin D1, and antitumor action.
...
http://www.ncbi.nlm.nih.gov/pubmed/12124352...

Roche - Herceptin proven to benefit women with HER2 positive early ...
11 Mar 2009 ... The patients were treated for one year with Herceptin and followed up for four years. These data from the HERA study were presented at the ...
http://www.roche.com/media/media_releases/med-cor-2009-03-11...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.